240 related articles for article (PubMed ID: 36348337)
21. A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles.
Wang L; Sebra RP; Sfakianos JP; Allette K; Wang W; Yoo S; Bhardwaj N; Schadt EE; Yao X; Galsky MD; Zhu J
Genome Med; 2020 Feb; 12(1):24. PubMed ID: 32111252
[TBL] [Abstract][Full Text] [Related]
22. Improving cell mixture deconvolution by identifying optimal DNA methylation libraries (IDOL).
Koestler DC; Jones MJ; Usset J; Christensen BC; Butler RA; Kobor MS; Wiencke JK; Kelsey KT
BMC Bioinformatics; 2016 Mar; 17():120. PubMed ID: 26956433
[TBL] [Abstract][Full Text] [Related]
23. Quantifying the proportion of different cell types in the human cortex using DNA methylation profiles.
Hannon E; Dempster EL; Davies JP; Chioza B; Blake GET; Burrage J; Policicchio S; Franklin A; Walker EM; Bamford RA; Schalkwyk LC; Mill J
BMC Biol; 2024 Jan; 22(1):17. PubMed ID: 38273288
[TBL] [Abstract][Full Text] [Related]
24. Down Syndrome Altered Cell Composition in Blood, Brain, and Buccal Swab Samples Profiled by DNA-Methylation-Based Cell-Type Deconvolution.
Zhang Z; Stolrow HG; Christensen BC; Salas LA
Cells; 2023 Apr; 12(8):. PubMed ID: 37190077
[TBL] [Abstract][Full Text] [Related]
25. Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software.
Decamps C; Privé F; Bacher R; Jost D; Waguet A; ; Houseman EA; Lurie E; Lutsik P; Milosavljevic A; Scherer M; Blum MGB; Richard M
BMC Bioinformatics; 2020 Jan; 21(1):16. PubMed ID: 31931698
[TBL] [Abstract][Full Text] [Related]
26. Cell-Type Deconvolution of Bulk DNA Methylation Data with EpiSCORE.
Zhu T; Teschendorff AE
Methods Mol Biol; 2023; 2629():23-42. PubMed ID: 36929072
[TBL] [Abstract][Full Text] [Related]
27. Benchmarking of methods for DNA methylome deconvolution.
De Ridder K; Che H; Leroy K; Thienpont B
Nat Commun; 2024 May; 15(1):4134. PubMed ID: 38755121
[TBL] [Abstract][Full Text] [Related]
28. Using epigenetic data to estimate immune composition in admixed samples.
Chakravarthy A; De Carvalho DD
Methods Enzymol; 2020; 636():77-92. PubMed ID: 32178828
[TBL] [Abstract][Full Text] [Related]
29. Estimating cell-type-specific DNA methylation effects in heterogeneous cellular populations.
Feng YA; Guo Y; Pain L; Lathrop GM; Laprise C; Moffatt MF; Cookson WO; Liang L
Epigenomics; 2021 Jan; 13(2):87-97. PubMed ID: 33350870
[No Abstract] [Full Text] [Related]
30. DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment.
Jeschke J; Collignon E; Fuks F
FEBS J; 2015 May; 282(9):1801-14. PubMed ID: 25331982
[TBL] [Abstract][Full Text] [Related]
31. Matched analysis of detailed peripheral blood and tumor immune microenvironment profiles in bladder cancer.
Chen JQ; Salas LA; Wiencke JK; Koestler DC; Molinaro AM; Andrew AS; Seigne JD; Karagas MR; Kelsey KT; Christensen BC
Epigenomics; 2024 Jan; 16(1):41-56. PubMed ID: 38221889
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
[TBL] [Abstract][Full Text] [Related]
33. Uncertainty quantification of reference-based cellular deconvolution algorithms.
Vellame DS; Shireby G; MacCalman A; Dempster EL; Burrage J; Gorrie-Stone T; Schalkwyk LS; Mill J; Hannon E
Epigenetics; 2023 Dec; 18(1):2137659. PubMed ID: 36539387
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
35. Complete deconvolution of DNA methylation signals from complex tissues: a geometric approach.
Zhang W; Wu H; Li Z
Bioinformatics; 2021 May; 37(8):1052-1059. PubMed ID: 33135072
[TBL] [Abstract][Full Text] [Related]
36. Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
Tang K; Kurland D; Vasudevaraja V; Serrano J; Delorenzo M; Radmanesh A; Thomas C; Spino M; Gardner S; Allen JC; Nicolaides T; Osorio DS; Finlay JL; Boué DR; Snuderl M
J Neuropathol Exp Neurol; 2020 Aug; 79(8):880-890. PubMed ID: 32594172
[TBL] [Abstract][Full Text] [Related]
37. Cell subpopulation deconvolution reveals breast cancer heterogeneity based on DNA methylation signature.
Wen Y; Wei Y; Zhang S; Li S; Liu H; Wang F; Zhao Y; Zhang D; Zhang Y
Brief Bioinform; 2017 May; 18(3):426-440. PubMed ID: 27016391
[TBL] [Abstract][Full Text] [Related]
38. Role of Epigenetic Regulation in Plasticity of Tumor Immune Microenvironment.
Yang Y; Wang Y
Front Immunol; 2021; 12():640369. PubMed ID: 33868269
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.
Perrier A; Didelot A; Laurent-Puig P; Blons H; Garinet S
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708698
[TBL] [Abstract][Full Text] [Related]
40. A Comprehensive Overview of RNA Deconvolution Methods and Their Application.
Im Y; Kim Y
Mol Cells; 2023 Feb; 46(2):99-105. PubMed ID: 36859474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
